Ascorbate is a reducing agent, but it is also known to oxidize cellular com
ponents under specific conditions. The mechanism of this oxidative action,
however, is not well established, Ascorbate treatment increased lipid perox
ide content in PC12 cells, but did not increase quantities of lipid peroxid
e when homogenates of PC12 cells were treated with ascorbate, suggesting th
at cellular integrity is required for ascorbate to generate lipid peroxidat
ion. However, dehydroascorbate increased lipid peroxide production in both
intact PC12 cells and the cell homogenates. These differential effects of a
scorbate and dehydroascorbate on intact cells versus homogenates suggest th
at the dehydroascorbate in cytosol induces an oxidative stress. Ascorbate i
n culture medium is rapidly oxidized to dehydroascorbate, which is transpor
ted into cells by a glucose transporter (GLUT). The GLUT antagonists wortma
nnin and cytochalasin B, or a high concentration of glucose, blocked C-14 u
ptake (from ascorbate) in a time-dependent manner and suppressed lipid pero
xide production in PC12 cells. These observations support the concept that
ascorbate is oxidized to dehydroascorbate, which is transported into cells
via GLUT. The dehydroascorbate induces oxidative stress. The oxidative stre
ss triggered apoptosis according to ceramide production, caspase-3 activati
on, and TUNEL, We have concluded that ascorbate is taken up after oxidation
to dehydroascorbate via a "dehydroascorbate transporter" (GLUT), and the d
ehydroascorbate generates an oxidative stress which triggers apoptosis, The
se studies have significant implications for conditions under which a high
concentration of ascorbate in a tissue is released during a period of hypox
ia (e.g., stroke) and taken up during a reperfusion period as dehydroascorb
ate. Inhibiting uptake of dehydroascorbate may offer novel therapeutic stra
tegies to alleviate brain damage during a reperfusion period. (C) 2001 Acad
emic Press.